Vision Sensing Acquisition (VSAC) Reports Definitive Merger Agreement with Mediforum
Shots:
- VSAC & Mediforum have signed a merger agreement for a proposed business combination to be listed on NASDAQ under a new ticker symbol
- The merger consideration for the transaction is $250M, with shareholders of the BVI company receiving 25M Class A ordinary shares of PubCo, valued at $10.00 per share, upon closing
- The merger will form a new company, PubCo, to facilitate the business combination and serve as the publicly traded holding company post-closure. Before closing, Mediforum will undergo restructuring and redomestication to the BVI. Merger Sub 1 (a BVI company) will merge with the BVI Company (Initial Merger), with the BVI Company as the surviving entity. Merger Sub 2 (a Delaware company) will merge with VSAC (SPAC Merger), with VSAC as the surviving entity. Both of them will be wholly owned subsidiaries of PubCo
Ref: Globenewswire | Image: Vision Sensing Acquisition
Related News:- AbbVie to Acquire ImmunoGen for $10.1B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
